SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-147481
Filing Date
2022-05-11
Accepted
2022-05-11 16:01:51
Documents
3
Period of Report
2022-05-11

Document Format Files

Seq Description Document Type Size
1 6-K d333178d6k.htm 6-K 9459
2 EX-99.1 d333178dex991.htm EX-99.1 93215
3 GRAPHIC g333178g07s30.jpg GRAPHIC 11668
  Complete submission text file 0001193125-22-147481.txt   119869
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 22913606
SIC: 2834 Pharmaceutical Preparations